Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 30 entries
View as:

A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01497470 Org: User:
Start: 04/30/12 End: 10/31/13 Due: 10/31/14

Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01188187 Org: User:
Start: 11/30/10 End: 06/30/14 Due: 06/30/15

Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00034164 Org: User:
Start: 04/30/02 End: 09/30/07 Due: 09/30/08

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00034190 Org: User:
Start: 03/31/02 End: 09/30/07 Due: 09/30/08

TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium

Phase: N/A Priority: Normal
NCT ID: NCT00077688 Org: User:
Start: 11/30/03 End: 09/30/07 Due: 09/30/08

Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokers

Phase: N/A Priority: Normal
NCT ID: NCT05981768 Org: User:
Start: 08/08/23 End: 09/21/23 Due: 09/21/24

A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers

Phase: N/A Priority: Normal
NCT ID: NCT03303911 Org: User:
Start: 10/06/17 End: 10/05/18 Due: 10/05/19

Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers

Phase: N/A Priority: Normal
NCT ID: NCT05566288 Org: User:
Start: 10/17/22 End: 12/23/22 Due: 12/23/23

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00034151 Org: User:
Start: 03/31/02 End: 09/30/07 Due: 09/30/08

Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00251095 Org: User:
Start: 09/30/05 End: 09/30/07 Due: 09/30/08

A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation

Phase: N/A Priority: Normal
NCT ID: NCT03509948 Org: User:
Start: 04/27/18 End: 06/12/18 Due: 06/12/19

Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose

Phase: N/A Priority: Normal
NCT ID: NCT05631938 Org: User:
Start: 01/10/23 End: 09/06/23 Due: 09/06/24

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Phase: N/A Priority: Normal
NCT ID: NCT01083615 Org: User:
Start: 03/31/10 End: 03/31/13 Due: 03/31/14

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01454089 Org: User:
Start: 10/31/11 End: 11/30/14 Due: 11/30/15

A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00138658 Org: User:
Start: 11/30/04 End: 03/31/10 Due: 03/31/11

A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine

Phase: N/A Priority: Normal
NCT ID: NCT03268343 Org: User:
Start: 08/08/17 End: 09/01/17 Due: 09/01/18

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01630733 Org: User:
Start: 09/30/12 End: 07/31/17 Due: 07/31/18

Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00385177 Org: User:
Start: 09/30/06 End: 05/31/09 Due: 05/31/10

Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00487786 Org: User:
Start: 06/30/07 End: 10/31/11 Due: 10/31/12

Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium

Phase: N/A Priority: Normal
NCT ID: NCT00034177 Org: User:
Start: 04/30/02 End: 09/30/07 Due: 09/30/08

Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization

Phase: N/A Priority: Normal
NCT ID: NCT01874561 Org: User:
Start: 05/31/13 End: 01/31/14 Due: 01/31/15

Trial of Cytisine in Adult Smokers

Phase: N/A Priority: Normal
NCT ID: NCT03709823 Org: User:
Start: 11/13/18 End: 04/23/19 Due: 04/23/20

Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01578655 Org: User:
Start: 08/31/12 End: 07/31/16 Due: 07/31/17

Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00096668 Org: User:
Start: 10/31/04 End: 09/30/07 Due: 09/30/08

A Study of Cytisinicline for Vaping Cessation in Adult Smokers

Phase: N/A Priority: Normal
NCT ID: NCT05431387 Org: User:
Start: 07/13/22 End: 02/28/23 Due: 02/28/24